Libros importados con hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada integrins & anti-integrins: links of the chain: autoimmune disease anti-integrins virus disease (in English)
Type
Physical Book
Publisher
Year
2006
Language
Inglés
Pages
196
Format
Paperback
Dimensions
21.6 x 14.0 x 1.1 cm
Weight
0.25 kg.
ISBN
0595401457
ISBN13
9780595401451

integrins & anti-integrins: links of the chain: autoimmune disease anti-integrins virus disease (in English)

Vanadiya Ermekova (Author) · iUniverse · Paperback

integrins & anti-integrins: links of the chain: autoimmune disease anti-integrins virus disease (in English) - Ermekova, Vanadiya

New Book

$ 13.56

$ 16.95

You save: $ 3.39

20% discount
  • Condition: New
It will be shipped from our warehouse between Monday, July 01 and Tuesday, July 02.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "integrins & anti-integrins: links of the chain: autoimmune disease anti-integrins virus disease (in English)"

Integrins play a critical role in numerous vital processes on the systemic, tissue, cell, and molecular levels. These include homeostasis; immunity; hematopoiesis; fertility and embryogenesis; cell proliferation, differentiation, cell cycle division and apoptosis; and gene expression. Impairment of integrins' functions causes the dramatic remodeling of these processes. Prolonged therapy with anti-α4β antibodies may result in severe pathological consequences, including generalized immunosuppression leading to an extreme risk of very serious infections; uncontrolled proliferation and altered differentiation of hematopoietic cells possibly leading to hematological abnormalities and increased risk of malignancies; and alterations in spermatogenesis, fertility, and embryonic development. Natalizumab (Tysabri) is an impressively effective drug. In the professional opinion of well-known neurologists it is considered to be a promising agent for the treatment of multiple sclerosis. However, whereas the evaluation of the drug's benefits can be done by neurologists alone, it is mandatory that the risk in using this agent should be assessed by a team of experts in a number of fields: immunology, infectious diseases, hematology, oncology, and embryology. It is essential to recognize that innovative integrin-antagonist therapy, e.g. therapy with anti-α4β integrin monoclonal antibodies, must be handled with extreme caution.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews